Ultragenyx Pharmaceutical Inc.

NASDAQ: RARE
$47.64
+$1.70 (+3.7%)
Closing price February 7, 2023
Friday's top analyst upgrades and downgrades included AMC Entertainment, CNH Industrial, Kala Pharmaceuticals, Opendoor Technologies, Tesla and TG Therapeutics.
Thursday's additional analyst upgrades and downgrades were on Alkermes, Altice USA, Fisker, Freshpet, Lincoln National, Maravai LifeSciences and more.
Friday's top analyst upgrades and downgrades included Altice USA, Apple, Colgate-Palmolive, Marathon Petroleum, Mastercard, Medtronic, Meta Platforms, Nike, Prologis, Realty Income, SLM, Tenaris and...
Tuesday's top analyst upgrades and downgrades included Canopy Growth, Constellation Brands, Equifax, FedEx, Franklin Resources, Micron Technology, Paramount Global, RH and T-Mobile.
Wednesday afternoon's top analyst upgrades and downgrades included Acadia Pharmaceuticals, Constellation Energy, Edwards Lifesciences, Host Hotels & Resorts, Johnson & Johnson and Magna International.
Friday afternoon's top analyst upgrades and downgrades included Affirm, AstraZeneca, Block, CVS, Kellogg and more.
Biotechnology was a huge laggard last year, but Truist Securities is out with its five top picks for 2022 that could see some sensational performance this year. Portfolio managers favor these...
24/7 Wall St. looks at some big analyst calls that we have seen so far on Thursday, including Nvidia, SeaWorld, Wells Fargo and Zoom Video.
Tuesday’s top analyst upgrades and downgrades included Coursera, CSX, Carvana, FedEx, Fox, Marathon, Petro China, Planet Fitness, Regeneron and Rackspace.
Analyst upgrades and downgrades seen Friday afternoon were on Capital One, Diageo, Wells Fargo and more.
24/7 Wall St. looks at some big analyst calls that we have seen so far on Thursday, including Allstate, Booking, CyberArk and Hilton.
The Christmas Eve top analyst upgrades and downgrades included Baidu, Fiserv, Virgin Galactic and Ultragenyx Pharmaceuticals.
Monday's top analyst upgrades and downgrades included Accenture, Boeing, CRISPR Therapeutics, DraftKings, Illumina, Lyft, McDonald's, Southwest Airlines and Teladoc Health.
These three biotech stocks have gigantic upside and a fair amount of risk as well. While they are not suited for conservative accounts, the companies all have had very positive data and their shares...
Wednesday's top analyst upgrades, downgrades and initiations included Altice USA, CenturyLink, Cigna, Emerson Electric, Foot Locker, Groupon, Lululemon Athletica, Nike, State Street and Walt Disney.